Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

HIV prevalence measurement in household surveys: is awareness of HIV status complicating the gold standard?

Korenromp EL, Gouws E, Barrere B.

AIDS. 2013 Jan 14;27(2):285-7. doi: 10.1097/QAD.0b013e32835816ce. No abstract available.

PMID:
23238553
2.

From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine.

Guy B, Barrere B, Malinowski C, Saville M, Teyssou R, Lang J.

Vaccine. 2011 Sep 23;29(42):7229-41. doi: 10.1016/j.vaccine.2011.06.094. Epub 2011 Jul 13. Review.

PMID:
21745521
3.

Evaluation of bias in HIV seroprevalence estimates from national household surveys.

Mishra V, Barrere B, Hong R, Khan S.

Sex Transm Infect. 2008 Aug;84 Suppl 1:i63-i70. doi: 10.1136/sti.2008.030411.

4.

High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production.

Barban V, Girerd Y, Aguirre M, Gulia S, Pétiard F, Riou P, Barrere B, Lang J.

Vaccine. 2007 Apr 12;25(15):2941-50. Epub 2006 Aug 1.

PMID:
16914238
5.

HIV testing in national population-based surveys: experience from the Demographic and Health Surveys.

Mishra V, Vaessen M, Boerma JT, Arnold F, Way A, Barrere B, Cross A, Hong R, Sangha J.

Bull World Health Organ. 2006 Jul;84(7):537-45.

6.

A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.

Guirakhoo F, Zhang Z, Myers G, Johnson BW, Pugachev K, Nichols R, Brown N, Levenbook I, Draper K, Cyrek S, Lang J, Fournier C, Barrere B, Delagrave S, Monath TP.

J Virol. 2004 Sep;78(18):9998-10008.

7.

Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates.

Guirakhoo F, Pugachev K, Zhang Z, Myers G, Levenbook I, Draper K, Lang J, Ocran S, Mitchell F, Parsons M, Brown N, Brandler S, Fournier C, Barrere B, Rizvi F, Travassos A, Nichols R, Trent D, Monath T.

J Virol. 2004 May;78(9):4761-75.

8.

Mechanism of neutralization of influenza virus infectivity by antibodies.

Knossow M, Gaudier M, Douglas A, Barrère B, Bizebard T, Barbey C, Gigant B, Skehel JJ.

Virology. 2002 Oct 25;302(2):294-8.

9.

Structural studies on viral escape from antibody neutralization.

Bizebard T, Barbey-Martin C, Fleury D, Gigant B, Barrère B, Skehel JJ, Knossow M.

Curr Top Microbiol Immunol. 2001;260:55-64. Review. No abstract available.

PMID:
11443881
10.

A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site.

Fleury D, Barrère B, Bizebard T, Daniels RS, Skehel JJ, Knossow M.

Nat Struct Biol. 1999 Jun;6(6):530-4.

PMID:
10360354
11.

An antibody which binds to the membrane-proximal end of influenza virus haemagglutinin (H3 subtype) inhibits the low-pH-induced conformational change and cell-cell fusion but does not neutralize virus.

Vanlandschoot P, Beirnaert E, Barrère B, Calder L, Millar B, Wharton S, Jou WM, Fiers W.

J Gen Virol. 1998 Jul;79 ( Pt 7):1781-91.

PMID:
9680143
12.

A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture.

Barrêre B, Driguez PA, Maudrin J, Doutheau A, Aymard M, Quash G.

Arch Virol. 1997 Jul;142(7):1365-1380. doi: 10.1007/s007050050166.

PMID:
28879398
13.

A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture.

Barrère B, Driguez PA, Maudrin J, Doutheau A, Aymard M, Quash G.

Arch Virol. 1997;142(7):1365-80.

PMID:
9267449
14.

Quantitative tissue sodium concentration mapping of normal rat brain.

Christensen JD, Barrère BJ, Boada FE, Vevea JM, Thulborn KR.

Magn Reson Med. 1996 Jul;36(1):83-9.

PMID:
8795025
15.

Brain stem energy metabolism response to acute hypoxia in anaesthetized rats: a 31P NMR study.

Piérard C, Champagnat J, Denavit-Saubie M, Gillet B, Beloeil JC, Guezennec CY, Barrère B, Pérès M.

Neuroreport. 1995 Dec 29;7(1):281-5.

PMID:
8742470
16.

Effects of a vigilance-enhancing drug, modafinil, on rat brain metabolism: a 2D COSY 1H-NMR study.

Piérard C, Satabin P, Lagarde D, Barrère B, Guezennec CY, Menu JP, Pérès M.

Brain Res. 1995 Sep 25;693(1-2):251-6.

PMID:
8653416
17.

Synthesis of transition-state analogues as potential inhibitors of sialidase from Influenza virus.

Driguez PA, Barrere B, Quash G, Doutheau A.

Carbohydr Res. 1994 Sep 15;262(2):297-310.

PMID:
7982221
18.

Effects of kainate-induced seizures on cerebral metabolism: a combined 1H and 31P NMR study in rat.

Meric P, Barrere B, Peres M, Gillet B, Berenger G, Beloeil JC, Seylaz J.

Brain Res. 1994 Feb 28;638(1-2):53-60.

PMID:
8199876
19.
20.

In vivo identification and monitoring of changes in rat brain glucose by two-dimensional shift-correlated 1H NMR spectroscopy.

Peres M, Fedeli O, Barrere B, Gillet B, Berenger G, Seylaz J, Beloeil JC.

Magn Reson Med. 1992 Oct;27(2):356-61.

PMID:
1361021
21.

Oesophageal candidiasis in primary HIV infection.

Lafeuillade A, Chaffanjon P, Pellegrino P, Andreotti D, Filippi JF, Barrère B, Delbeke E, Quilichini R.

Eur J Med. 1992 May;1(2):126. No abstract available.

PMID:
1342373
22.

Two-dimensional 1H spectroscopic imaging for evaluating the local metabolic response to focal ischemia in the conscious rat.

Peres M, Bourgeois D, Roussel S, Lefur Y, Devoulon P, Remy C, Barrere B, Decorps M, Pinard E, Riche D, et al.

NMR Biomed. 1992 Jan-Feb;5(1):11-9.

PMID:
1550705
23.

Mortality trends in Abidjan, Côte d'Ivoire, 1983-1988.

De Cock KM, Barrere B, Lafontaine MF, Diaby L, Gnaore E, Pantobe D, Odehouri K.

AIDS. 1991 Apr;5(4):393-8.

PMID:
1647789
24.

AIDS--the leading cause of adult death in the West African City of Abidjan, Ivory Coast.

De Cock KM, Barrere B, Diaby L, Lafontaine MF, Gnaore E, Porter A, Pantobe D, Lafontant GC, Dago-Akribi A, Ette M, et al.

Science. 1990 Aug 17;249(4970):793-6.

PMID:
2167515
25.

Cerebral intracellular pH regulation during hypercapnia in unanesthetized rats: a 31P nuclear magnetic resonance spectroscopy study.

Barrere B, Meric P, Borredon J, Berenger G, Beloeil JC, Seylaz J.

Brain Res. 1990 May 21;516(2):215-21.

PMID:
2364288
26.

2D COSY 1H NMR: a new tool for studying in situ brain metabolism in the living animal.

Barrère B, Peres M, Gillet B, Mergui S, Beloeil JC, Seylaz J.

FEBS Lett. 1990 May 21;264(2):198-202.

27.

Rapid emergence of AIDS in Abidjan, Ivory Coast.

De Cock KM, Porter A, Odehouri K, Barrere B, Moreau J, Diaby L, Kouadio JC, Heyward WL.

Lancet. 1989 Aug 19;2(8660):408-11.

PMID:
2569598
28.

In vivo 31P nuclear magnetic resonance (NMR) study of cerebral metabolism during histotoxic hypoxia in mice.

Peres M, Meric P, Barrere B, Pasquier C, Beranger G, Beloeil JC, Lallemand JY, Seylaz J.

Metab Brain Dis. 1988 Mar;3(1):37-48.

PMID:
3211074
29.

[Results of a systematic survey used in detecting thalassemia in school environment in Corsica].

Orsini A, Vovan L, Pancrazi J, Barrère B, Abino JF.

Pediatrie. 1977 Oct-Nov;32(7):651-8. French. No abstract available.

PMID:
928032
30.

[Reversible blood accident due to Thiamphenicol (value of hematological surveillance)].

Pascal F, Radureau FP, Barrere B, Buresi D.

Mars Med. 1972;109(7):507-10. French. No abstract available.

PMID:
4637692
31.

[Discovery of thalassemia during investigation of 3 cases of occupational lead posioning].

Gadrat J, Monnier J, Bourse R, Pascal JP, Barrère B.

Arch Mal Prof. 1966 Jul-Aug;27(7):622-5. French. No abstract available.

PMID:
5942757

Supplemental Content

Loading ...
Support Center